Mono- and dicationic Re(I)/99mTc(I) tricarbonyl complexes for the targeting of energized mitochondria
摘要:
The enhanced negative mitochondrial membrane potential of tumor cells can increase the cell accumulation of triphenylphosphonium (TPP) derivatives, which prompted us to investigate TPP-containing Re(I)/Tc-99m organometallic compounds as probes for in vivo targeting of energized mitochondria. Novel compounds (Re1-Re4/Tc1-Tc4) were obtained with bifunctional chelators of the pyrazole-diamine (N,N,N-donors) and pyrazole-aminocarboxylic (N,N,O-donors) type, functionalized with TPP pharmacophores that have been introduced at the central amine of the chelators using different spacers. In this way, dicationic (Re1-Re2, Tc1-Tc2) and monocationic (Re3-Re4, Tc3-Tc4) complexes with variable lipophilicity were synthesized. The Tc-99m complexes (Tc1-Tc4) are highly stable under physiological conditions and their chemical identification was done by HPLC comparison with the Re congeners (Re1-Re4), which were fully characterized by common analytical techniques (electrospray ionization mass spectrometry (ESI-MS), IR, multinuclear NMR). The in vitro biological evaluation of Tc1-Tc4 was performed in a panel of human tumor cell lines (PC-3, MCF-7 and H69), including cell lines overexpressing P-glycoprotein (MCF-7/MDR1 and H69/Lx4), and in isolated mitochondria. All the tested complexes showed a low to moderate cellular and mitochondrial uptake and did not undergo significant P-glycoprotein (Pgp)-mediated efflux processes. In particular, the dication Tc2 and the monocation Tc4 presented the highest cellular and mitochondrial uptake. Their cellular uptake was shown to depend on the mitochondrial (Delta psi(m)) and plasma membrane (Delta psi(p)) potentials. Altogether, the biological properties of these compounds suggest that they might be relevant for the design of radioactive metalloprobes for in vivo targeting of mitochondria. (C) 2013 Elsevier Inc. All rights reserved.
Isostructural Re(<scp>i</scp>)/<sup>99m</sup>Tc(<scp>i</scp>) tricarbonyl complexes for cancer theranostics
作者:Patrique Nunes、Goreti Ribeiro Morais、Elisa Palma、Francisco Silva、Maria Cristina Oliveira、Vera F. C. Ferreira、Filipa Mendes、Lurdes Gano、Hugo Vicente Miranda、Tiago F. Outeiro、Isabel Santos、António Paulo
DOI:10.1039/c5ob00124b
日期:——
Novel cysteamine-based (N,S,O)-chelators were successfully applied in the synthesis of isostructural M(i) (M = Re, 99mTc) tricarbonyl complexes for cancer theranostics.
Long-chain rhenium and technetium glucosamine conjugates
作者:Meryn L. Bowen、Zhen-Feng Chen、Adrienne M. Roos、Ripen Misri、Urs Häfeli、Michael J. Adam、Chris Orvig
DOI:10.1039/b914309b
日期:——
A series of five glucosamine-conjugated organometallic complexes of the tricarbonyl cores of technetium-99m and rhenium were made. Glucosamine was derivatized at the C-2 nitrogen with long chain alkyl spacers linked to either pyridyl-tert-nitrogen-phenol tridentate chelates or cyclopentadienyl ligating groups. The metal complexes of the tridentate ligands were formed by refluxing with [Re(CO)3(H2O)3]Br, or with a base and [99mTc(CO)3(H2O)3]+. These ligands were found to be competent chelates in binding the [99mTc(CO)3]+ core as radiolabeling yields ranged from 87 to 93% and the resulting complexes are stable to cysteine and histidine challenges for 24 h. The cyclopentadienyl analogues were formed using a double ligand transfer reaction for the rhenium complexes and a single ligand transfer for the technetium-99m complexes. All five rhenium complexes were tested as substrates of hexokinase; two of these complexes were tested as hexokinase inhibitors and they were found to be competent inhibitors, suggesting that they may be able to interact with hexokinase. MTT cytotoxicity studies were performed and the complexes tested were found to be non-toxic to the concentrations tested (100 μM or 1 mM). GLUT-1 mediated cell uptake studies were performed on all five technetium-99m complexes, and their cell entry was found to parallel their lipophilicities, suggesting that cellular uptake is by passive diffusion and is not mediated by GLUT-1.
New (Radio)metalated G4 binders: Re(I) and 99mTc(I) complexes carrying pyridostatin derivatives for the targeting of G-quadruplex structures. The Recomplex can bind to G4 DNA and RNA with selectivity over double-stranded DNA, exhibiting cytotoxic activity in MCF-7 human breast cancer and PC3 human prostate cancercell lines. The 99mTc congener is stable in vivo with a fast blood clearance in normal
新型(放射性)金属化 G4 结合剂:带有吡啶他汀衍生物的 Re(I) 和99m Tc(I) 配合物,用于靶向 G-四链体结构。 Re 复合物可以比双链 DNA 选择性地结合 G4 DNA 和 RNA,在 MCF-7 人乳腺癌和 PC3 人前列腺癌细胞系中表现出细胞毒活性。 99m Tc 同源物在体内稳定,在正常小鼠中具有快速的血液清除率。